Omeros Corp Appoints Joseph Schocken to Board and Audit Committee

What Happened
Omeros Corporation (OMER) announced on August 12, 2026 that its Board increased the number of directors to nine and appointed Joseph Schocken as a director, effective immediately. Mr. Schocken was also named to the Board’s Audit Committee; his initial term runs until the 2027 annual meeting of shareholders (or earlier if he resigns or is removed).

Key Details

• Appointment date: August 12, 2026; Board size increased to nine directors.
• Director term: expires at the 2027 annual meeting (or earlier upon resignation/removal).
• Committee assignment: added to the Audit Committee.
• Compensation: granted a stock option to purchase 30,000 shares under the company’s non-employee director compensation policy.
• Background: Mr. Schocken (age 79) is founder/president of Tranceka Capital, LLC; founder of Broadmark Capital LLC; former CEO/chair of entities that became Broadmark Realty Capital, Inc. (NYSE). He holds an MBA from Harvard and a BA from the University of Washington.
• Other corporate/legal notes: he will be indemnified under Omeros’ standard director indemnification agreement and reported no arrangements or related-party interests requiring Item 404 disclosure.

Why It Matters
Board appointments can affect governance oversight, especially when the new director joins the Audit Committee, which oversees financial reporting and controls. Investors should note the timing (effective Aug. 12, 2026), the 30,000-share option grant as standard non-employee director compensation, and that the company disclosed no related-party transactions tied to his appointment.